Condition: Atrial Fibrillation · Stroke · Sponsor: Conformal Medical, Inc
The CLAAS® device will be evaluated for safety and efficacy by establishing its performance is non-inferior to the commercially available WATCHMAN® and Amulet™ left atrial appendage closure devices in patients with non-valvular atrial fibrillation. Patients who are eligible for the trial will be randomized to receive either the CLAAS device or the WATCHMAN or Amulet™ devices and will be followed for 5 years after device implant.
This description comes directly from the study's public registry record.
Sarah Gallagher · 952-270-8356 · sgallagher@conformalmedical.com
Always discuss trial participation with your own doctor first.
| Grandview Medical Center | Birmingham, Alabama, United States | Recruiting |
| Banner University Medical Center Phoenix | Phoenix, Arizona, United States | Recruiting |
| Abrazo Arizona Heart Hospital | Phoenix, Arizona, United States | Active Not Recruiting |
| Arizona Heart Arrhythmia Associates | Phoenix, Arizona, United States | Recruiting |
| HonorHealth | Scottsdale, Arizona, United States | Recruiting |
| Pima Heart & Vascular | Tucson, Arizona, United States | Recruiting |
| St. Bernard's Medical Center | Jonesboro, Arkansas, United States | Recruiting |
| Loma Linda University Health | Loma Linda, California, United States | Recruiting |
| Huntington Hospital | Pasadena, California, United States | Recruiting |
| Pacific Heart Institute | Santa Monica, California, United States | Recruiting |
| Community Memorial Hospital Ventura | Ventura, California, United States | Recruiting |
| South Denver Cardiology Associates | Littleton, Colorado, United States | Recruiting |
+ 81 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.